The Legacy Of Angels is located in Waseca, MN. The organization was established in 2009. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Legacy Of Angels is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Legacy Of Angels generated $2.3m in total revenue. The organization has seen a slow decline revenue. Over the past 8 years, revenues have fallen by an average of (2.7%) each year. All expenses for the organization totaled $2.5m during the year ending 12/2023. As we would expect to see with falling revenues, expenses have declined by (5.0%) per year over the past 8 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, Legacy Of Angels has awarded 110 individual grants totaling $19,842,350. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Paul Rosenau President | 5 | $0 | |
Gillian Hauboldt Treasurer | 2 | $0 | |
Mariah Stone Mary Kay Delvo Secretary | 2 | $0 | |
Heather Techmeier Director | 40 | $127,500 | |
Dr Gabriel Cohn Director | 40 | $175,000 | |
Julie Mccarrier Director | 2 | $0 |
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $11,000 |
| Interest on Savings | $1,836 |
| Dividends & Interest | $848,561 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $1,331,521 |
| Capital Gain Net Income | $1,331,521 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $123,878 |
| Total Revenue | $2,316,796 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $302,500 |
| Other employee salaries and wages | $0 |
| Pension plans, employee benefits | $88,408 |
| Interest | $0 |
| Taxes | $32,179 |
| Depreciation | $0 |
| Occupancy | $0 |
| Travel, conferences, and meetings | $10,528 |
| Printing and publications | $0 |
| Other expenses | $389,250 |
| Total operating and administrative expenses | $1,226,562 |
| Contributions, gifts, grants paid | $1,266,475 |
| Total expenses and disbursements | $2,493,037 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $484 |
| Savings and temporary cash investments | $215,910 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $7,523 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $2,255,922 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $0 |
| Total assets | $30,291,573 |
| Accounts payable and accrued expenses | $759 |
| Grants payable | $1,339,690 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $1,340,449 |
Over the last fiscal year, The Legacy Of Angels has awarded $2,606,165 in support to 20 organizations.
| Grant Recipient | Amount |
|---|---|
UNIVERSITY OF ILLINOIS PURPOSE: IMMUNE RESPONSES IN PERIPHERAL NERVES AFTER HEMATOPOIETIC STEM CELL TRANSPLANTS FOR KD | $125,000 |
UNIVERSITY OF ILLINOIS PURPOSE: CHALLENGING THE CAPACITY OF AAV-GALC GENE THERAPY TO COPE WITH MODIFIERS OF ADULT BRAIN FUNCTION | $85,000 |
UNIVERSITY OF BUFFALO PURPOSE: INNOVATIVE MODEL SYSTEMS TO STUDY & BOOST INNATE IMMUNITY IN KD | $205,983 |
BIOMEDICAL RESEARCH INSTITUTE OF NJ PURPOSE: PSYCHOSINE PROFILING AND EVALUATION AS A THERAPEUTIC FOR KD | $129,834 |
UNIVERSITY OF CONNECTICUT HEALTH CE PURPOSE: EVALUATION OF IMMUNOMODULATORY THERAPY FOR THE TREATMENT OF KD | $17,950 |
KRABBECONNECT PURPOSE: PARENT-REPORTED DISEASE BURDEN IN INFANTILE & LATE INFANTILE KD | $122,708 |